DocGo

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services and Mobile Health Solutions. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

DocGo reports stellar 2022 performance and outlines growth strategies

DocGo's strong financial performance in 2022, coupled with robust guidance for 2023 and strategic operational initiatives, positions the company for continued growth and profitability.
While challenges like managing PHE impacts and transitioning to leased hour contracts exist, DocGo's proactive approach and operational strengths provide a solid foundation for addressing these hurdles.
With a focus on optimizing operations, pursuing growth opportunities, and leveraging its financial resources effectively, DocGo is poised to capitalize on market opportunities and deliver value to stakeholders.

DocGo reports Q1 revenue growth amidst margin challenges and future opportunities

DocGo's Q1 2023 performance showcased revenue growth and margin challenges, with a focus on improving margins through normalization initiatives.
Strengths include strong revenue guidance, significant contract opportunities, and partnerships driving backlog growth and revenue diversification.
Challenges stem from replacing high-margin COVID revenue, startup costs impacting margins, and negative cash flow in Q1 2023.
Opportunities lie in future revenue growth from new contracts, RPM services, public-private partnerships, and potential contract wins from upcoming RFPs.

DocGo (DCGO) reports stellar Q2 results, raises full-year guidance

DocGo's Q2 2023 showcased exceptional financial performance, with revenue and EBITDA growth exceeding expectations, underpinned by strong operational metrics and strategic decisions.
While facing challenges in backlog conversion and margin improvements, the company's focus on scalability, employee satisfaction, and market expansion positions it well for future growth.
Opportunities in new geographies, Remote Patient Monitoring integration, and transportation segment enhancements provide avenues for sustained revenue growth and operational excellence.

DocGo reports record Q3 revenue, eyes growth in commercial sector

DocGo's Q3 performance reflects strong revenue growth and improved EBITDA margins, driven by the success of Mobile Health and Transportation Services. While facing challenges with working capital and payment delays, the company is focused on catching up by year-end.
The company's strengths in contract performance, revenue guidance increase, and backlog diversification position it well for future growth. DocGo's strategic focus on commercial business expansion and customer experience enhancement aligns with its growth objectives.

DocGo reports record Q4 earnings, eyes growth in healthcare

DocGo delivered exceptional financial results in Q4 2023, showcasing robust revenue growth and profitability, driven by operational excellence and strategic investments.
While facing margin and cost challenges, the company's focus on growth, value-based care agreements, and revenue diversification positions it well for future success and market expansion.
With a strong cash position, revised revenue guidance, and proactive pursuit of new partnerships, DocGo is poised to capitalize on growth opportunities and navigate challenges effectively.
The company's commitment to transforming healthcare delivery and gratitude towards its staff underscore a resilient corporate culture and a dedication to driving positive impact in the industry.

DocGo reports robust Q1 earnings, eyes growth through unique care model

DocGo's Q1 2024 performance was strong, marked by revenue growth, improved margins, and profitability.
While facing challenges like revenue fluctuations and working capital pressures, the company is well-positioned for growth.
Opportunities lie in becoming a primary care provider, monetization strategies, and market differentiation through quality care.
Overall, DocGo's financial stability, growth plans, and unique service offerings position them for future success in the healthcare sector.

DocGo excels in Q2 2024, sets sights on clinical innovation

DocGo's Q2 2024 performance reflects financial strength and strategic advancements in clinical expertise and service expansion.
While facing challenges in meeting ambitious care gap closure targets, the company is well-positioned for growth.
Leveraging opportunities in mobile healthcare services and clinical program development can drive future success for DocGo.

DocGo reports robust Q3 earnings, eyes growth in migrant-related work

DocGo's Q3 2024 earnings call showcased strong financial performance, operational efficiency, and positive outlook for future revenue and cash flow.
While challenges such as revenue balancing and margin expectations were noted, opportunities for growth through migrant-related work and care programs were highlighted.
Overall, DocGo's performance and strategic direction position the company well for continued success and expansion in the healthcare sector.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DocGo, Inc. engages in the provision of mobile health services. It operates through the following segments: Transportation Services, Mobile Health Solutions, and Corporate. The Transportation Services segment offers on-demand medical mobility solutions which are marketed under the Ambulnz brand. The Mobile Health Solutions segment includes on-site evaluations, diagnostics, triage, treatment, and medicine administration. The Corporate segment consists of information technology expenses. The company was founded in 2015 by Stanley Vashovsky and is headquartered in New York, NY.

We saw our previous prediction of municipal contracts helping cushion DocGo's revenue (absent of the Covid test) work out for its full year of 2022. The technological advantage in operations and low debt burden combined with ample liquidity put the company on a strong footing for future growth.

DocGo: Strong Showing Overall With Potential Fast Topline Growth

DocGo Inc, a last-mile health services company, continues to prove it can successfully replace its COVID testing revenue after it posted 4Q results that beat expectations, according to analysts at Canaccord Genuity (TSX:CF, LSE:CF). In a note to clients, the analysts highlighted that DocGo's results beat both their and the consensus estimates for the quarter.

DocGo earns repeat ‘Buy' rating from Canaccord on proven ability to replace COVID testing revenue

DocGo Inc (NASDAQ: DCGO) has emerged as a buyable growth stock for 2023, which is saying something. The fallout from SVB's collapse is yet to be felt and will impact growth names this year.

DocGo: A Growth Stock Going Higher In 2023

Start Time: 17:00 January 1, 0000 5:41 PM ET DocGo Inc. (NASDAQ:DCGO ) Q4 2022 Earnings Conference Call March 13, 2023, 17:00 PM ET Company Participants Anthony Capone - CEO Norman Rosenberg - CFO Lee Bienstock - President and COO Mike Cole - Vice President, IR Conference Call Participants Richard Close - Canaccord Genuity Ryan MacDonald - Needham & Company David Grossman - Stifel Kieran Ryan - Deutsche Bank Operator Greetings, and welcome to the DocGo Fourth Quarter and Full Year 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.

DocGo Inc. (DCGO) Q4 2022 Earnings Call Transcript

DocGo Inc. (DCGO) delivered earnings and revenue surprises of 120% and 4.47%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

DocGo Inc. (DCGO) Tops Q4 Earnings and Revenue Estimates

DocGo Inc posted full-year 2022 and fourth quarter results after the bell Monday, but its 2023 guidance is what caught investors' attention. DocGo projects 2023 revenue between $500 million to $510 million, which would represent growth of 14% to 16% over 2022 on an as-reported basis.

Last-mile health services company DocGo stock surges on 2023 revenue guidance

NEW YORK--(BUSINESS WIRE)--DocGo Inc. awarded $180M in new business in the US and UK since January 2023, showing strong growth across key service lines.

DocGo Awarded $180M in New Business in the United States, United Kingdom Since January as Demand for Mobile Healthcare Grows

NEW YORK--(BUSINESS WIRE)--DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced financial and operating results for the fourth quarter and full-year ended December 31, 2022. Full Year 2022 Financial Highlights Full-year 2022 revenue increased to $440.5 million, compared to $318.7 million for the full-year 2021, an increase of 38%. Gross Margin for 2022 was 35% compared to 34% in 2021. Mobile Health revenue was approximately $325.

DocGo Announces Fourth Quarter and Full-Year 2022 Results

DocGo Inc is expected to extend its track record of beating consensus estimates when it reports its fourth-quarter earnings on March 13, according to Canaccord Genuity (TSX:CF, LSE:CF) analysts. In a note to clients, the analysts forecast 2023 revenue for the provider of mobile medical services and transportation of $487.1 million, representing year-over-year growth of 12% and 34% when excluding COVID.

Preview: DocGo expected to extend its track record of beating estimates, analysts say

NEW YORK--(BUSINESS WIRE)--DocGo CEO Anthony Capone will present at Cowen's 43rd Annual Healthcare Conference and virtually at the 33rd Annual Oppenheimer Healthcare Conference.

DocGo Announces Upcoming Participation in Two Investor Conferences

NEW YORK--(BUSINESS WIRE)--DocGo, a leading provider of last-mile mobile health services (Nasdaq: DCGO), today announced that the company will report results for the fourth quarter and full-year ended December 31, 2022, after the markets close on Monday, March 13th. Management will host a conference call for analysts and investors at 5:00pm ET on that day. Conference call and webcast details: Monday, March 13th, 5:00pm ET 1-877-407-0784 (U.S.

DocGo to Announce Fourth Quarter and Full-Year 2022 Results on Monday, March 13

NEW YORK--( BUSINESS WIRE )--DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced a partnership with Redirect Health, a platform that creates and manages healthcare solutions for businesses and employees nationwide, to provide on-demand, urgent mobile care to patients in New Jersey and New York. Through Redirect Health's referral team, DocGo On-Demand mobile services are called into action, preventing potential emergency room visits and ultimately lowering costs while facilitating high-quality patient care. The partnership will enable DocGo to provide its rapid, in-home mobile health services to thousands of Redirect Health's members across New Jersey and New York.

DocGo Partners with Redirect Health to Deliver Affordable, On-Demand Urgent Mobile Healthcare to Redirect Health Patients in New Jersey and New York

COVID has pulled forward consumer adoption of telehealth. DocGo offers a fully integrated platform.

DocGo: Can Sustain Rapid, Profitable Expansion

Boeing

Caterpillar

Celsius Holdings

Clearfield

Vita Coco

Chevron

Enphase Energy

JPMorgan Chase & Co

McDonald's

Merck

Noble Corp PLC

Northern Oil and Gas

Nuvalent

Permian Basin Royalty Trust

Pinduoduo Inc - ADR

Tidewater

TG Therapeutics

Mammoth Energy Services

Visa

Vipshop Hlds

Viridian Therapeutics

Verizon

Wave Life Sciences

Two new Breakout Stocks for Week 1 with better than 10% short-term upside potential and two Dow 30 Picks. Average cumulative returns for 2022 reached +142.69% YTD. The streak of weekly picks gaining over 10% in less than a week of trading days has reached 235 out of 293 trading weeks (80.4%) not counting multiple gainers.

MDA Breakout Stocks Week 1 - January 2023: High-Frequency Gainers To Give You An Edge

NEW YORK--( BUSINESS WIRE )--DocGo Inc. (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that its co-founder and current Chairman of the Board and Chief Executive Officer Stan Vashovsky will continue to serve as non-executive Chairman of its Board of Directors beginning on January 1, 2023 and following his retirement as Chief Executive Officer of the Company. The company had previously announced that Mr. Vashovsky will retire as Chief Executive Officer of the Company as of December 31, 2022 and step down from the Board of Directors and his Chairman position at the same time. The company believes it is in its best interests to have Mr. Vashovsky continue to serve as Chairman given DocGo's strong growth outlook. Ira Smedra, who was to succeed Mr. Vashovsky as Chairman on January 1, 2023, will continue serving as a member of DocGo's Board of Directors. As previously disclosed, current President Anthony Capone will succeed Mr. Vashovsky as Chief Executive Officer beginning on January 1, 2023.

DocGo Announces Stan Vashovsky to Continue to Serve as Chairman of its Board of Directors

NEW YORK--( BUSINESS WIRE )--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that its UK subsidiary, Ambulnz Community Partners, has been awarded a new mobile health care contract to provide Rapid Falls Response Service. This offering will provide a quicker response to help elderly patients recover from falls without requiring a trip to the emergency room, and establishes clinical pathways to help prevent future incidents.

DocGo Awarded New Mobile Healthcare Contract in the UK

NEW YORK--( BUSINESS WIRE )--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced the release of its annual Social Impact and Sustainability Report. The report provides an overview of the progress DocGo has made across a range of Environmental, Social, and Governance (ESG) programs.

DocGo Releases Annual ESG Report, Outlining Commitment to Ethical Mobile Healthcare Initiatives

NEW YORK--( BUSINESS WIRE )--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, President, will participate in Benchmark Company's 11th Annual Discovery One-on-One Investor Conference to be held Thursday, December 1st, 2022 at the New York Athletic Club in New York City. Mr. Capone is scheduled to participate in one-on-one meetings with institutional analysts and investors throughout the day.

DocGo to Present at the Benchmark Company's Upcoming Discovery One-on-One Investor Conference

DocGo Q3 beat topline revenue but missed bottom-line earnings; however, that was due to accounting for a one-time loss from the remeasurement of warrant liabilities. The end of Covid Testing did not materially impact its revenue stream, while its long-term municipal contracts are looking to expand, serving as a recession cushion.

DocGo: Current Post-Earnings Sell-Off Presents Double-Digit Upside Potential

NEW YORK--( BUSINESS WIRE )--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced that it has appointed veteran human resources executive Vina Leite, MS, to its Board of Directors. Ms. Leite brings to the DocGo Board more than two decades of leadership, with experience transforming technology-driven high growth and Fortune 500 organizations by closely aligning human resources with corporate goals to achieve optimal outcomes. The company also announced key leadership promotions that will be effective December 31, 2022.

DocGo Appoints Veteran Technology Human Resources Executive Vina Leite, MS, to its Board of Directors and Announces Key Leadership Promotions

NEW YORK--( BUSINESS WIRE )--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced a partnership with Hiring Our Heroes, a nationwide initiative of the U.S. Chamber of Commerce Foundation to help veterans, transitioning service members, military spouses and caregivers find meaningful employment.

DocGo Launches Program to Hire Military Community Members Through Partnership with Hiring Our Heroes

NEW YORK--(BUSINESS WIRE)--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, announced today that Anthony Capone, President will participate at the following four investor conferences during the month of November: Citi Consumer Dirsputive Growth Conference on Monday, November 14 at 8:30AM Eastern Time.

DocGo Announces Upcoming Participation in Four Investor Conferences

DocGo Inc. (NASDAQ:DCGO ) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Mike Cole - Vice President, IR Stan Vashovsky - CEO, Co-Founder Andre Oberholzer - CFO Anthony Capone - President Conference Call Participants Matt Shae - Needham Sarah James - Barclays Richard Close - Canaccord Genuity Kieran Ryan - Deutsche Bank Mike Latimore - Northland Securities David Grossman - Stifel Operator Thank you for standing by. This is the conference operator.

DocGo Inc. (DCGO) Q3 2022 Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)--DocGo Announces Q3 2022 Results: Q3 Revenue of $104.3 Million Up 22% YOY; Company Raises Full-Year 2022 Revenue and Adjusted EBITDA Guidance.

DocGo Announces Strong Third Quarter 2022 Results

NEW YORK--(BUSINESS WIRE)--DocGo Announces $90 Million Line of Credit with Citibank, N.A.

News for DocGo Stock (DCGO)